Inventor · disambiguated record
Craig Siegel
Also filed as: SIEGEL CRAIG · SIEGEL CRAIG S
42 granted patents·10 pending applications·1,871 citations·filing 1980–2022
99Inventor score
Top patents by PatentIndex Score
52 records- 0197US6855830B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2002·Granted Feb 15, 2005·67 cites·2 claims
- 0296US7763738B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2007·Granted Jul 27, 2010·28 cites·5 claims
- 0396US7615573B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsUNIV MICHIGAN·Filed 2007·Granted Nov 10, 2009·36 cites·30 claims
- 0496US7196205B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2005·Granted Mar 27, 2007·51 cites·16 claims
- 0596US5948767ACationic amphiphile/DNA complexesGENZYME CORP·Filed 1996·Granted Sep 7, 1999·271 cites·13 claims
- 0695US10954230B2Method of preparing glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2020·Granted Mar 23, 2021·4 cites·3 claims
- 0795US7253185B2Amino ceramide-like compounds and therapeutic methods of useGENZYME CORP·Filed 2005·Granted Aug 7, 2007·49 cites·4 claims
- 0895US6916802B2Amino ceramide-like compounds and therapeutic methods of useUNIV MICHIGAN·Filed 2004·Granted Jul 12, 2005·64 cites·14 claims
- 0995US5767099ACationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Jun 16, 1998·201 cites·22 claims
- 1094US7265228B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2004·Granted Sep 4, 2007·34 cites·16 claims
- 1194US5783565ACationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Jul 21, 1998·123 cites·4 claims
- 1294US5719131ACationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Feb 17, 1998·119 cites·24 claims
- 1392US10604518B2Method of preparing glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2018·Granted Mar 31, 2020·5 cites·7 claims
- 1492US6071890AOrgan-specific targeting of cationic amphiphile/DNA complexes for gene therapyGENZYME CORP·Filed 1995·Granted Jun 6, 2000·128 cites·14 claims
- 1590US10065949B2Method of preparing glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted Sep 4, 2018·8 cites·7 claims
- 1690US8304447B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2008·Granted Nov 6, 2012·18 cites·20 claims
- 1789US9682975B2Method of preparing glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Jun 20, 2017·10 cites·7 claims
- 1889US5935936ACompositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 10, 1999·85 cites·20 claims
- 1989US5650096ACationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1994·Granted Jul 22, 1997·92 cites·7 claims
- 2088US8309593B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2009·Granted Nov 13, 2012·15 cites·15 claims
- 2188US8138353B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsHIRTH BRADFORD H·Filed 2010·Granted Mar 20, 2012·7 cites·6 claims
- 2288US5925628ACationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1997·Granted Jul 20, 1999·66 cites·22 claims
- 2387US8940776B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Jan 27, 2015·11 cites·19 claims
- 2484US9546161B2Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitorsGENZYME CORP·Filed 2014·Granted Jan 17, 2017·3 cites·3 claims
- 2584US9518049B2Salt forms of (S)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamateGENZYME CORP·Filed 2014·Granted Dec 13, 2016·7 cites·24 claims
- 2684US8779163B2Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitorsHIRTH BRADFORD H·Filed 2012·Granted Jul 15, 2014·4 cites·3 claims
- 2782US9272996B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Mar 1, 2016·6 cites·16 claims
- 2882US5948925ACationic amphiphiles containing linkers derived from neutral or positively charged amino acidsGENZYME CORP·Filed 1997·Granted Sep 7, 1999·49 cites·14 claims
- 2981US5939401ACationic amphiphile compositions for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 17, 1999·37 cites·5 claims
- 3080US5840710ACationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Nov 24, 1998·51 cites·36 claims
- 3179US9745294B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Aug 29, 2017·3 cites·24 claims
- 3277US12465586B2Inhibitors of glucosylceramide synthaseGENZYME CORP·Filed 2022·Granted Nov 11, 2025·0 cites·7 claims
- 3377US4281771AChild-resistant/non-child-resistant closureSIEGEL CRAIG S·Filed 1980·Granted Aug 4, 1981·48 cites·8 claims
- 3475US5910487ACationic amphiphiles and plasmids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Jun 8, 1999·28 cites·7 claims
- 3575US2021171507A1Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2020·Application pending·0 cites
- 3674US6383814B1Cationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1999·Granted May 7, 2002·32 cites·16 claims
- 3774US5942634ACationic amphiphiles for cell transfectionsGENZYME CORP·Filed 1997·Granted Aug 24, 1999·27 cites·11 claims
- 3872US9744153B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2016·Granted Aug 29, 2017·1 cites·14 claims
- 3971US2021393590A1Inhibitors of glucosylceramide synthaseGENZYME CORP·Filed 2021·Application pending·0 cites
- 4071US2019322649A1Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2018·Application pending·0 cites
- 4169US5747471ACationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted May 5, 1998·37 cites·20 claims
- 4269US2021369672A1Inhibitors of glucosylceramide synthaseGENZYME CORP·Filed 2021·Application pending·0 cites
- 4367US11458119B2Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthaseLIU HANLAN·Filed 2010·Granted Oct 4, 2022·1 cites·25 claims
- 4466US2017334888A1Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2016·Application pending·0 cites
- 4560US5912239AImidazole-containing cationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1997·Granted Jun 15, 1999·22 cites·6 claims
- 4660US2016120842A1Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthaseGENZYME CORP·Filed 2016·Application pending·0 cites
- 4760US2009312392A1Amino ceramide-like compounds and therapeutic methods of useSHAYMAN JAMES A·Filed 2009·Application pending·0 cites
- 4857US2018093981A12-Acylaminopropoanol-Type Glucosylceramide Synthase InhibitorsGENZYME CORP·Filed 2017·Application pending·0 cites
- 4956US5952516ACationic amphiphiles containing multiplesteroid lipophilic groupsGENZYME CORP·Filed 1997·Granted Sep 14, 1999·12 cites·10 claims
- 5055US6331524B1Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapyGENZYME CORP·Filed 1997·Granted Dec 18, 2001·11 cites·4 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →